Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,525,290 papers from all fields of science
Search
Sign In
Create Free Account
Chronic electrode implant
Known as:
Chronic Electrode Implants
A chronic electrode implant is an electronic device implanted chronically (for a long period) into the brain or other electrically excitable tissue…
Expand
Wikipedia
(opens in a new tab)
Create Alert
Alert
Related topics
Related topics
5 relations
Auditory brainstem implant
Brain implant
Cochlear implant
Deep brain stimulation
Broader (1)
Neuroprosthetics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An Open-Label, Phase 2, Dose-Finding Study of Sotatercept (ACE-011) in Patients with Low or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndromes (MDS) or Non-Proliferative Chronic Myelomonocytic…
R. Komrokji
,
G. Garcia-Manero
,
+14 authors
A. List
2014
Corpus ID: 78912346
Introduction: Anemia, a hallmark of MDS, is challenging to treat, particularly after failure of erythropoiesis-stimulating agents…
Expand
2007
2007
The polycomb group BMI 1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia
M. Mohty
,
A. Yong
,
Richard Szydlo
,
J. Apperley
,
J. Melo
2007
Corpus ID: 20690757
Because the polycomb group gene BMI1 regulates the proliferation of both normal and leukemic stem cells, we examined whether BMI1…
Expand
2005
2005
Atomistic analysis of the evolution of boron activation during annealing in crystalline and preamorphized silicon
M. Aboy
,
L. Pelaz
,
L. Marqués
,
P. López
,
J. Barbolla
,
R. Duffy
2005
Corpus ID: 55578685
We use kinetic nonlattice Monte Carlo atomistic simulations to investigate the physical mechanisms for boron cluster formation…
Expand
2005
2005
Dasatinib (BMS-354825) Overcomes Multiple Mechanisms of Imatinib Resistance in Chronic Myeloid Leukemia (CML).
F. Lee
,
M. Wen
,
+12 authors
L. Lombardo
2005
Corpus ID: 78128736
Resistance to imatinib is a growing concern in CML, particularly in advanced disease. The most common cause of resistance is…
Expand
2004
2004
Imatinib mesylate ( STI 571 ) for treatment of children with Philadelphia chromosome – positive leukemia : results from a Children ’ s Oncology Group phase 1 study
M. Champagne
,
R. Capdeville
,
+7 authors
M. Bernstein
2004
Corpus ID: 7312356
The purpose of this study was to determine dose-limiting toxicities and pharmacokinetics of imatinib in children with refractory…
Expand
Review
2004
Review
2004
CASE REPORT: Sarcoidosis After Use of Interferon for Chronic Hepatitis C: Report of a Case and Review of the Literature
V. Tahan
,
F. Ozşeker
,
+7 authors
H. Senturk
Digestive Diseases and Sciences
2004
Corpus ID: 26930912
Although interferon has not been classified in the pathogenesis of sarcoidosis, it may rarely lead to this disease during…
Expand
2003
2003
Atomistic modeling of deactivation and reactivation mechanisms in high-concentration boron profiles
M. Aboy
,
L. Pelaz
,
+5 authors
J. Plummer
2003
Corpus ID: 56353660
We use kinetic nonlattice Monte Carlo atomistic simulations to investigate the physical mechanisms for boron cluster formation…
Expand
1993
1993
Mortality and Cancer Incidence 1952-1990 in UK Participants in the UK Atmospheric Nuclear Weapon Tests and Experimental Programmes
S. Darby
1993
Corpus ID: 70722306
In order to study the long-term effects of participating in the United Kingdom’s atmospheric nuclear weapon tests and…
Expand
Highly Cited
1979
Highly Cited
1979
Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML).
Eaves Ac
,
Eaves Cj
1979
Corpus ID: 88790289
: Peripheral blood and bone marrow specimens from 6 patients with Ph1-positive CML were evaluated for their content of…
Expand
1976
1976
The Role of Cytogenetics in Hematology
J. Rowley
1976
Corpus ID: 6844240
identify a group of hematologic disorders characterized by proliferation of one or more of the cell types that occur in the bone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE